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ABSTRACT
Genome-wide mutations and selection within a
population are the basis of natural evolution.
A similar process occurs during antibody affinity
maturation when immunoglobulin genes are hyper-
mutated and only those B cells which express
antibodies of improved antigen-binding specificity
are expanded. Protein evolution might be simulated
in cell culture, if transgene-specific hypermutation
can be combined with the selection of cells carrying
beneficial mutations. Here, we describe the optimi-
zation of a GFP transgene in the B cell line DT40 by
hypermutation and iterative fluorescence activated
cell sorting. Artificial evolution in DT40 offers unique
advantages and may be easily adapted to other
transgenes, if the selection for desirable mutations
is feasible.
INTRODUCTION
Natural evolution, based on the selection of beneﬁcial
mutations within a population of genetic variants, has
created the amazing diversity of life on our planet. While
natural selection works on whole genomes, the evolution
of individual proteins can be tracked by the analysis of
intra-species polymorphisms and inter-species divergence.
A fascinating example for the evolution of a single protein
by mutation and selection is the aﬃnity maturation of
antibodies in B cells (1). Developing B cells activate and
diversify their immunoglobulin (Ig) genes by recombina-
tion, but only cells encoding antibodies with antigen-
binding speciﬁcity are stimulated to expand after antigen
challenge. These B cells hypermutate their Ig genes
and cycles of hypermutation and selection continue until
antibodies of suﬃciently high antigen-binding aﬃnity
emerge.
Recombinant DNA technologies are able to recapitu-
late the evolution of proteins by mutagenesis and selection
in vitro. Most approaches combine the expression of
diverse gene libraries in phage, bacteria or translation
systems with selection for the encoded proteins (2,3). If the
structure-function relationship of a protein is suﬃciently
understood, site-directed mutagenesis of critical amino
acids can be used instead or in addition to random
mutagenesis (4). The potential of in vitro protein evolution
is illustrated by the example of the green ﬂuorescent
protein (GFP) (5) which could be changed into yellow,
cyan or blue variants by random and site-directed
mutagenesis and selection in vitro (6–8).
Aﬃnity maturation of antibodies can be simulated
ex vivo in cultures of hypermutating B cell lines by the
enrichment of cells expressing antigen-speciﬁc antibodies
(9,10). B cell lines could also be used for the optimization
of non-immunoglobulin proteins, if the hypermutating
activity were directed toward transfected transgenes
and cells carrying beneﬁcial mutations were selected.
Advantages of this approach are the possibilities to
generate an enormous amount of genetic diversity and
to select for improved protein variants within a living
cell culture. It was recently reported that a gene encoding
a red ﬂuorescent protein (FP) was transferred into the
hypermutating human B cell line RAMOS, and the
selection of cells emitting red-shifted ﬂuorescence yielded
the most far red-shifted FP protein known to date (11).
Despite this impressive result, hypermutation is dif-
ﬁcult to control in RAMOS, because transgenes usually
integrate at random chromosomal sites outside the
hypermutating Ig loci. In contrast, transgenes can be
easily inserted into the Ig loci of the chicken B cell line
DT40 (12). DT40 diversiﬁes its rearranged Ig light chain
gene by pseudo V (cV) gene-templated gene conversion
Present address:
Hiroaki Kudo, Graduate School of Medicine, Kyoto University, Yoshida Konoe, Sakyo-ku, Kyoto 606-8501, Japan
*To whom correspondence should be addressed. Tel: +49 89 3187 2871; Fax: +49 89 3187 4093; Email: buersted@gsf.de
 2007 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.(13), but if gene conversion is blocked due to the
inactivation of RAD51 paralogues or the deletion of
gene conversion donors, hypermutation occurs (14,15).
Ig gene diversiﬁcation by conversion or hypermutation
requires expression of the AID gene (15,16). Based on
these results, we reasoned that transgenes inserted into the
Ig loci of DT40 without nearby gene conversion donors
would be diversiﬁed by hypermutation in AID positive
cells. To test this hypothesis, we inserted the enhanced
GFP (eGFP) gene (17) into the rearranged Ig light chain
locus and searched for cells displaying increased ﬂuores-
cence. Only three rounds of ﬂuorescence activated cell
sorting (FACS) were suﬃcient to isolate cells expressing
eGFP variants whose ﬂuorescent intensity appears to
be superior to the best GFPs currently available for
vertebrate cell labeling.
MATERIALS AND METHODS
Celllines
Cells were cultured in chicken medium (RPMI-1640 or
DMEM/F-12 with 10% fetal bovine serum, 1% chicken
serum, 2mM L-glutamine, 0.1mM b-mercaptoethanol
and penicillin/streptmycin) at 418C with 5% CO2. The
AID expressing DT40 clones, AID
R1CL1 and AID
R1CL2,
used in the study for hypermutation were derived from the
AID knockout cell clone DT40
Cre1AID
/ (16) by stable
transfection of a ﬂoxed AID—IRES (internal ribosome
entry site)—gpt (guanine phosphoribosyl transferase)
bicistronic cassette. The IRES sequence was derived
from Encephalomyocarditis virus. Because the bi-cistronic
cassette is driven by the strong b-actin promoter and since
AID is the ﬁrst gene downstream of the promoter, AID
protein expression in AID
R1CL1 and CL2 is higher than
in wild-type DT40 cells (unpublished data). The cell clones
express the Cre recombinase as a MerCreMer fusion
protein which is inactive due to its retention in the
endoplasmic reticulum in the absence of estrogen deriva-
tives (18). However, since background activity of
MerCreMer can lead to undesired excision of the ﬂoxed
AID-gpt expression cassette during prolonged culture,
we selected for cells retaining AID by culturing in media
containing 0.5mg/ml of mycophenolic acid for 3 days
following each preparative FACS sort.
An AID negative subclone of AID
R1Cl1 was generated
by culturing the cells in chicken medium containing 1mM
4-hydroxitamoxifen (SIGMA) for 2 days and subsequent
subcloning.
TargetedintegrationoftransgenesintotherearrangedIglocus
Cells were transfected by electroporation using the
Gene Pulser Xcell (BIO-RAD) at 25mF and 700V (16)
and stable transfectants were selected for using 1mg/ml
of puromycin. Transfectants having integrated the
pHypermut1- or pHypermut2-derived constructs by tar-
geted integration were identiﬁed by PCR using primer
pairs P1/P2 and P1/P3, respectively. The frequency of
targeted integration after transfection of pHypermut
constructs was consistently more than 70% (data not
shown). Since the constructs can target either the
rearranged or the unrearranged Ig locus of DT40,
integration into the rearranged Ig light chain locus was
veriﬁed by PCR ampliﬁcation of the VJ intervening
sequence of the unrearranged locus using primer pairs of
P4/P5.
Flow cytometry
To quantify the appearance of GFP negative cells
within proliferating cultures, the AID
R1IgL
eGFP1,
AID
/IgL
eGFP1 and cVAID
R1IgL
eGFP clones were sub-
cloned by limited dilution, and 24 subclones of each were
analyzed 2 weeks after subcloning by FACS. The
preparative FACS sorts to select cells of increased
ﬂuorescence were performed using the MoFlo high-speed
cell sorter (Cytomation).
PCR, cloningand sequencing
The screenings for targeted integration and the ampliﬁca-
tion of the eGFP transgenes were performed with the
expand long template PCR system (Roche) under the
following conditions: 2min of initial incubation at 938C;
35 cycles consisting of 10s at 938C, 30s at 658C and 5min
(plus an added 20s per cycle) at 688C and a ﬁnal
elongation step of 7min at 688C. The primer pair for the
ampliﬁcation of the eGFP gene from sorted cells was
P6/P7. The PCR products were digested with HindIII
and XbaI, cloned into the pUC119 plasmid vector and
sequenced using primers P8 and P9. The mutated eGFP
genes were then ampliﬁed using Pfu Ultra hotstart
polymerase (Stratagene) and primer pair P10/P11,
digested by AvrII and cloned into the NheI site of
pHypermut2. The orientation and the sequence of the
mutant eGFPs in pHypermut2 was veriﬁed by sequencing
using primers P12 and P13.
Site-directed mutagenesis
To combine the codon changes found in diﬀerent eGFP
variants, we designed primers (P14–P26) which included
the intended mutations in the center of the primer
sequence. In the ﬁrst step, parts of the eGFP gene were
ampliﬁed by PCR using at least one mutation-containing
primer. In the second step, PCR fragments containing
mutations were mixed with other PCR fragments to cover
the full eGFP coding sequence. This mixture served as
a template for chimeric PCR using the primer pair of
P10/P11. The full length mutant eGFP PCR fragments
were digested with AvrII and cloned into the NheI site
of pHypermut2. The orientation and the sequence of
the mutant eGFPs in pHypermut2 were conﬁrmed by
sequencing.
Primers
P1 GGGACTAGTAAAATGATGCATAACCTTTTG
CACA
P2 CGATTGAAGAACTCATTCCACTCAAATATA
CCC
P3 CCCACCGACTCTAGAGGATCATAATCAGCC
P4 TACAAAAACCTCCTGCCAGTGCAAGGAGCA
GCTGATGGTTTTTACTGTCT
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TGATAGAAACT
P6 GGGAAGCTTTGGGAAATACTGGTGATAGG
TGGAT
P7 GGGTCTAGACCTCTCAGCTTTTTCAGCAGA
ATAACCTCC
P8 GGTATAAAAGGGCATCGAGGTCCCCGGCAC
P9 AGTTCGAGGGCGACACCCTGGTGAACCGCA
P10 GAACCTAGGGCCACCATGGTGAGCAAGGG
CGAGGA
P11 GAACCTAGGACTTGTACAGCTCGTCCATG
CCG
P12 CCTAGCTCGATACAATAAACGCCATTTGAC
P13 TGGCTTCGGTCGGAGCCATGGAGATC
P14 AACGGCATCAAGGcGAACTTCAAGATC
P15 GATCTTGAAGTTCgCCTTATGCCGTT
P16 CCCGACCACATGAAGgAGCACGACTTCTTC
P17 GAAGAAGTCGTGCTcCTTCATGTGGTCGGG
P18 GATCACATGGTCCTGgTGGAGTTCGTGACC
P20 GGTCACGAACTCCAcCAGGACCATGTGATC
P21 GCCGACCACTACCAGgAGAACACCCCCATC
P22 GATGGGGGTGTTCTcCTGGTAGTGGTCGGC
P23 CTGAgCACCCAGTCCaCCCTGAgCAAAGAC
P24 GTCTTTGcTCAGGGtGGACTGGGTGcTCAG
P25 ATCCTGGGGCACAAGgTGGAGTACAACT
P26 AGTTGTACTCCAcCTTGTGCCCCAGGAT
Color spectrum
Excitation and emission spectra were analyzed by the
luminescence spectrometer LS50B (Perkin Elmer). One
million cells were washed once with PBS, resuspended in
2ml of PBS, and then used for spectrum analysis. The
relative ability to excite by lasers of diﬀerent wavelengths
was measured at ﬁxed emission of 540nm wavelength. The
relative emission intensities at diﬀerent wavelengths were
measured after ﬁxed excitation at 460nm wavelength.
RESULTS
Targeted integration of the eGFPgene into therearranged
Ig lightchain locus
The eGFP coding sequence was inserted into the
pHypermut1 vector and transfected into the DT40 variant,
AID
R1CL1, which is deleted for both alleles of the
endogenous AID gene and expresses AID as a ﬂoxed
cDNA expression cassette (16). Clones which had
integrated the construct into the rearranged Ig light
chain locus were identiﬁed by PCR. Transcription of
the eGFP gene in these clones is supposed to be driven by
the Ig light chain promoter and terminated by the SV40
polyA signal (Figure 1A). The clones contained two ﬂoxed
transgenes, the bsr marker gene co-inserted in the
rearranged Ig light chain locus and the AID-IRES-gpt
gene of the AID
R1 progenitor clone. To remove the bsr
marker alone or together with the AID expression cassette,
Cre recombinase was induced by tamoxifen before
subcloning by limited dilution (16). In this way, AID
positive (AID
R1IgL
eGFP1) and negative (AID
/IgL
eGFP1)
clones could be isolated which had deleted the bsr marker
gene from the light chain locus.
Evidence forhypermutation of theeGFP transgene
The AID
R1IgL
eGFP1 and AID
/IgL
eGFP1 clones were
subcloned by limited dilution and 24 subclones of each
were analyzed by FACS for GFP brightness 14 days after
subcloning. Subclones of the AID
R1IgL
eGFP1 clone con-
tained cell populations showing lower (3.8%) and higher
(0.5%) ﬂuorescence than the dominant GFP positive cell
population, whereas subclones of the AID
/IgL
eGFP1
clone consisted only of a homogeneous GFP positive
population (Figure 1B). This suggests that the eGFP gene
inserted into the rearranged Ig light chain locus is
diversiﬁed in AID
R1IgL
eGFP1 cells giving rise to variants
of increased and decreased ﬂuorescent intensity.
Mutation activity ofartificial evolution system
To analyze the mutation spectrum of the eGFP trans-
genes, the coding sequence was ampliﬁed by PCR from
AID
R1IgL
eGFP1 and AID
/IgL
eGFP1 cells 6 weeks after
subcloning, cloned into a plasmid vector and sequenced.
A total of 13nt changes were found within the 0.7kb
eGFP coding region of 39 sequences from the
AID
R1IgL
eGFP1 clone (Table 1). Assuming a DT40
doubling time of 10h, the mutation rate of the eGFP
coding region in the rearranged Ig light chain locus of
AID
R1IgL
eGFP1 cells is approximately 4.7 10
6 muta-
tions per base pair and division. This mutation frequency
is approximately three times lower than the mutation rate
of the rearranged VJ segment in the pseudogene deleted
cV
AID
R cell line (15) perhaps reﬂecting the lower
incidence of hypermutation hotspots in the eGFP
sequence. In both cases, the majority of mutations
occurred at C/G base pairs (Table 1). Only 1nt change
which possibly represents a PCR artifact was found in
26 sequences of the AID
/IgL
eGFP1 clone conﬁrming that
the mutation activity of the eGFP transgene is dependent
on AID.
Sortingand sequence analysis of cells displaying increased
fluorescence
The FACS analysis suggested that a few cells within the
AID
R1IgL
eGFP1 culture had accumulated mutations which
increased either the abundance or the ﬂuorescent intensity
of the eGFP protein. To enrich these cells, 10 million
AID
R1IgL
eGFP1 cells were sorted by preparative FACS
using a gate which included only the 0.05% brightest cells
(Figure 1C). The cells collected by the FACS sort were
expanded and cycles of preparative cell sorting and
expansion were repeated twice. Three consecutive sorts
were performed independently for three AID
R1IgL
eGFP1
subclones.
To trace the rise of mutations responsible for the
increased ﬂuorescence, the coding sequences of the eGFP
genes were ampliﬁed by PCR from cells after the ﬁrst and
the third sort, cloned into a plasmid vector and sequenced.
Unexpectedly, few mutations and no obvious mutation
signatures were found in the eGFP coding sequence after
the ﬁrst sort (Table 1) despite the fact that the sorted cells
displayed increased ﬂuorescence (Figure 1C). We therefore
extended the sequence analysis to the region downstream
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Figure 1. Strategy for artiﬁcial evolution of eGFP gene. (A) A physical map of the chicken rearranged Ig light chain locus, the pHypermut1-eGFP
targeting construct and the rearranged Ig light chain locus after targeted integration and marker excision is shown. The positions of primers used for
the identiﬁcation of targeted integration events are shown by arrows. (B) FACS proﬁles of AID
R1IgL
eGFP1 and AID
/IgL
eGFP1 clones. The average
percentages of events falling into the GFP
high and GFP
low gates based on the measurement of 24 subclones are shown. (C) Sorting strategy for cells
of increased ﬂuorescence activity.
Table 1. Mutation proﬁle
Cell source Gene Mutations Number of
sequences
Mutations/
sequence
Mutations at Duplication Deletion
CG A T
AID
/IgLe
GFP1 6-week culture eGFP (723bp) 1 26 0.04 0 0 1 0 0 0
AID
R1IgL
eGFP1 6-week culture eGFP (723bp) 13 39 0.33 5 8 0 0 1 0
AID
R1IgL
eGFP1 Sort I eGFP (723bp)
a 15 95 0.16 8 6 1 0 0 0
AID
R1IgL
eGFP1 Sort I polyA-L (300bp)
a 88 95 0.93 1 87 0 0 0 0
AID
R1IgL
eGFP1 Sort III eGFP (723bp) 221 85 2.60 130 93 6 4 0 0
aTheir sequences were derived from the diﬀerent region of the same plasmids.
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analysis revealed frequent mutations at the splice donor
site of the Ig light chain leader intron (88 mutations/95
seq) (Figure 2A, Table 1). Although the role of these
mutations downstream of the eGFP polyA signal remains
speculative, it is possible that they enhance ﬂuorescence by
increasing eGFP mRNA stability.
In contrast, most of the sequences after the third sort
showed mutations in the eGFP coding sequence (221
mutations/85 seq) (Figure 2B, Table 1). Comparison of
the sequences of each sorted subclone allowed us to
reconstruct evolutionary trees showing the stepwise
accumulation of eGFP codon changes (Figure 2C).
Many of the codon changes were not shared by diﬀerent
subclones and their functional signiﬁcance remains
uncertain. However, a number of codon changes occurred
independently in diﬀerent subclones suggesting that they
are related to the increased ﬂuorescence of the sorted cells.
Mutated eGFP sequences which were found more than
once were named GFP variants (GFPv1–9).
Development ofanewvector fortransgeneevolution inDT40
Although we were able to use pHypermut1 for the
enhancement of eGFP, this vector is not ideally suited
for transgene evolution in DT40, as mutations outside the
transgene coding region had apparently been selected for
after the ﬁrst sort. We therefore developed a new targeting
vector named pHypermut2 in which the expression of the
transgene is unlikely to be inﬂuenced by mutations of the
rearranged Ig light chain gene, because transgene tran-
scription is driven by the Rous sarcoma virus (RSV)
promoter in the opposite direction of the light chain gene
(Figure 3A). pHypermut2 allows transgenes to be cloned
into multiple cloning sites (NheI, EcoRV and BglII). The
vector’s puromycin resistance (puroR) cassette, located
downstream of the transgene can be excised by Cre
recombinase (19), but it is unlikely to interfere with
transgene transcription or mutagenesis. A convenient
feature of pHypermut2 is the presence of a SpeI site
upstream of the RSV promoter which can be used for the
insertion of gene conversion donor sequences (20).
We inserted the eGFP transgene into pHypermut2, and
transfected the construct into the cV
AID
R1 cell line (15)
(Figure 3B). To estimate the hypermutation rate within
the eGFP transgene, one of the stable transfected clones
cV
AID
R1IgL
eGFP, having integrated the construct into
the rearranged Ig light chain locus, was subcloned by
limited dilution. FACS analysis of 24 subclones after
14 days of culture revealed that on average 10.9% of the
cells showed decreased or lost ﬂuorescence (Figure 3C).
This result indicates that transgenes inserted by
pHypermut2 into the rearranged Ig light chain locus are
eﬃciently diversiﬁed by hypermutation.
Confirmation of thevariant GFP phenotypes
The phenotype of mutations is best conﬁrmed by re-
transfection into the genetically stable AID
/ clone and
the analysis of transfectants which have integrated the
gene as a single copy into the rearranged locus. The
pHypermut2 vector is well suited for this task and all
isolated GFP variants, as well as the eGFP and the
Emerald (8) control sequences, were cloned into
pHypermut2. These constructs were then transfected into
AID
/. More than 50% of all stable transfectants had
integrated the constructs into the rearranged light chain
locus and these clones were named according to the
inserted transgene (AID
/IgL
eGFP, AID
/IgL
Emerald,
AID
/IgL
GFPv1, etc.).
The ﬂuorescent intensity of the diﬀerent transfectants
was compared by FACS (Figure 4A). Two independent
transfectants of each variant GFP gene were included
in the experiment to account for variation among trans-
fectants of the same gene. This analysis revealed that
the Emerald transfectant was 1.2 times brighter than the
eGFP transfectant, four of the nine GFP variant
transfectants (AID
/IgL
GFPv2, AID
/IgL
GFPv5,
AID
/-gL
GFPv6 and AID
/IgL
GFPv8) were brighter
than the eGFP transfectant. Three variant GFP transfec-
tants (AID
/IgL
GFPv5, AID
/IgL
GFPv6 and
AID
/IgL
GFPv8) had even higher ﬂuorescent intensity
than the Emerald transfectant (Table 2). Of all
variant GFP transfectants, AID
/IgL
GFPv6 had the
highest ﬂuorescent intensity (2.5-fold more than
the AID
/IgL
eGFP) and AID
/IgL
GFPv5 had the
second highest intensity (2.0-fold brighter than the
AID
/IgL
eGFP) (Figure 4A, Table 2). Little ﬂuorescent
variation was observed among transfectants of the same
transgene.
To compare the ﬂuorescent intensity of eGFP and
GFPv6 in human cells, the pHypermut2 constructs of
GFPv6 and eGFP were transiently transfected into the
human embryonic kidney cell line HEK293T. By FACS
analysis, cells transfected with the GFPv6 construct
showed on average more ﬂuorescence than cells trans-
fected with the eGFP construct (data not shown).
Increasedfluorescence by thecombination ofmutations
As certain combinations of codon changes were not found
among the GFP variants, we wondered whether the
accumulation of mutations in a single sequence may
lead to further enhancement of ﬂuorescent intensity
(Figure 4B). At ﬁrst, we combined Y145F and S202T of
GFPv6 with V163A of GFPv5 to produce GFPv10.
Because GFPv1 harboring the single Q80E mutation
showed less ﬂuorescent intensity than eGFP, we sub-
tracted Q80E from GFPv10 to generate GFPv11. We also
added L221V of GFPv8 to GFPv11, thereby generating
GFPv12. Finally, we added Q184E and A206T of GFPv2
as well as L141V of GFPv9 to GFPv12 to generate
GFPv13. These new variants were cloned into pHypermut2
and inserted into the rearranged Ig light chain locus of the
clone AID
/.
Transfectants of all new GFP variants showed higher
ﬂuorescent intensity than AID
/IgL
GFPv6 by FACS
analysis (Figure 4C, Table 2). AID
/IgL
GFPv10 had 3.0-
fold higher ﬂuorescent intensity than AID
/IgL
eGFP, but
AID
/IgL
GFPv11 and AID
/IgL
GFPv12 were even
brighter, displaying 3.2- and 3.3-fold more ﬂuorescence
respectively than AID
/IgL
eGFP. AID
/IgL
GFPv13 did
not surpass the ﬂuorescent intensity of the other variant
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Figure 2. Mutations downstream and within the eGFP transgene. (A) Mutations identiﬁed at the exon/intron border of the Ig light chain leader
sequence. The number of times a mutation was found is shown by superscript. (B) Mutations within the eGFP coding sequence. Mutations were
mapped below the reference eGFP sequence together with the corresponding amino acid codons. The eGFP sequence which we used had one codon
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which oﬀer the most potential for the labeling of
vertebrate cells were named GFPnovo1 and GFPnovo2,
respectively.
Spectral properties ofthe new GFP variants
The excitation and the emission maximum of eGFP are
at 488 and 509nm wavelength, respectively (7,8). To
determine the spectral proﬁles of the new variant GFP
proteins, the control and variant gene transfectants
(AID
/IgL
eGFP, AID
/IgL
Emerald, AID
/IgL
GFPv5,
AID
/IgL
GFPv6, AID
/IgL
GFPnovo1 and the AID
/
IgL
GFPnovo2) were analyzed using a luminescence spectro-
meter (Figure 4D). This analysis showed that the
ﬂuorescent intensity, but not the excitation and emission
spectra had been changed in the variant GFP transfec-
tants. The lack of mutants showing altered excitation or
emission properties is most likely due to our selection
strategy which only enriched cells for increased ﬂuorescent
intensity.
We also examined cells of the eGFP, Emerald and
variant GFP transfectants by ﬂuorescence microscopy
(Figure 4E). Consistent with the FACS and spectrometer
analysis, cells of the GFPv5, GFPv6, GFPnovo1 and
GFPnovo2 transfectants produced brighter images than
cells of the eGFP and Emerald transfectants, but there was
no noticeable change of color.
DISCUSSION
We describe here an artiﬁcial evolution system in the B cell
line DT40 which oﬀers advantages over alternative
approaches and could be of generic value for the
optimization of many types of proteins in cell culture.
The main advantages are the high transgene-speciﬁc
mutation rates, the easy conﬁrmation of mutant
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within the environment of live vertebrate cells. We have
illustrated the utility of the system by generating new GFP
variants which display more than 3-fold higher ﬂuores-
cence activity than the best GFPs currently available for
bio-imaging of vertebrate cells.
We have chosen eGFP as a ﬁrst example for protein
evolution in DT40, because the protein has been
extensively optimized by random and site-directed muta-
genesis and selection of cells displaying brighter ﬂuores-
cence is straightforward. Only three rounds of FACS
sorting during 2 months of culturing were suﬃcient to
isolate mutants of increased ﬂuorescent intensity. Some of
the identiﬁed mutations are identical to mutations
previously reported by others for GFP variants with an
altered excitation and/or emission spectrum. For example,
the V163A codon substitution is included in the GFP
variants Cycle3 (7), T-Sapphire (20), Venus (21–23), ECFP
(8) and W1C (8); Y145F is shared by the GFP variants
Sapphire (20), p4-3 (8) and EBFP (7,8); L221V is shared by
EGFPevo mutants (24). It has been proposed that the
V163A substitution facilitates the correct folding and
maturation of GFP (6). Other amino acid changes such as
S202T and A206T are ﬁrst described in this study.
Although the crystal structure of GFP is resolved (25) it
is not easy to explain the increased ﬂuorescence of our
variant GFP transfectants without more detailed studies of
the encoded mRNAs and proteins. As the conﬁguration of
the GFP chromophore has already been optimized, the
most likely reason seems to be improved protein matura-
tion or stability. The amino acid substitutions A206T and
L221V are localized in a region known to inﬂuence
GFP dimerization and their eﬀect might be due to the
enhancement of dimer formation, but other eﬀects cannot
be ruled out. Regardless of the molecular basis, the
increased ﬂuorescence conferred by the new GFP variants
and in particular GFPnovo1 and GFPnovo2 should be
useful in situations where maximal sensitivity is required
for bio-imaging.
Compared to alternative artiﬁcial evolution techniques,
protein optimization in hypermutating B cell lines like
DT40 has the advantage that it is performed within the
real life environment of a vertebrate cell. This can be
important as the properties of many proteins are aﬀected
by intra-cellular parameters such as pH and salt concen-
trations, folding, post-translational modiﬁcations and
degradation. Although optimization of proteins has
been achieved in hypermutating mammalian B cell lines
such as Ramos (11) or 18–81 (24), DT40 oﬀers the
advantages that transgenes can be inserted as single
copies into the Ig light chain locus and AID expression
can be controlled. In the future, transgene diversiﬁcation
in DT40 may be accomplished by a combination of
hypermutation and gene conversion if homologous con-
version donor sequences are inserted upstream of the
transgene. It has already been demonstrated that gene
conversion can be used for the diversiﬁcation of trans-
genes in DT40 (20).
The high eﬃciency of targeted gene integration in DT40
allows one to standardize the hypermutation of transgenes
and the conﬁrmation of mutant phenotypes (Figure 5).
We envision that the transgene of interest is ﬁrst cloned
into the pHypermut2 vector and then transfected into
a DT40 clone which conditionally expresses AID.
Transfectants, which hypermutate the transgene after
targeted integration into the rearranged Ig light chain
locus, are subjected to iterative cycles of cell selection
and expansion. When a cell population of the desired
phenotype is isolated, hypermutation is shut oﬀ by
excision of the AID expression cassette and the cells are
subcloned. Transgene sequences from the most promising
subclones are ampliﬁed by PCR and cloned into the
pHypermut2 vector for sequencing. In the end, the
mutated transgenes within the pHypermut2 vector are
Table 2. Amino acid changes and brightness of GFP variants
GFP variant Amino acid changes Number of
sequences
Subclone Relative
brightness
a
eGFP Change from wild-type GFP – –- 1.00.1
1aG, F64L, S65T, H231L, 239S
Change from eGFP
GFPv1 Q80E 28 1, 2, 3 0.70.0
GFPv2 Q80E, Q184E, A206T 19 1 1.20.0
GFPv3 Q80E, E124D, L141V, Y237stop 11 3 0.30.0
GFPv4 Q80E, S202T 4 1, 2 0.90.1
GFPv5 Q80E, V163A 4 1 2.00.0
GFPv6 Q80E, Y145F, S202T 3 2 2.50.0
GFPv7 Q80E, S208T 2 3 0.70.1
GFPv8 Q80E, L221V 2 3 1.50.3
GFPv9 Q80E, L141V, S202I 5 3 1.00.1
GFPv10 Q80E, Y145F, V163A, S202T – – 3.00.1
GFPv11 (GFPnovo1) Y145F, V163A, S202T – – 3.20.0
GFPv12 (GFPnovo2) Y145F, V163A, S202T, L221V – – 3.30.0
GFPv13 L141V, Y145F, V163A, Q184E, S202T, A206T, L221V – – 2.90.1
Emerald Change from wild-type GFP – – 1.2
S65T, S72A, N149K, M153T, I167T
aSDS based on the analysis of two clones.
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phenotype.
In principle, DT40 can be used for the evolution of any
coding or non-coding sequence whose transcription is
tolerated. However, evolution of transgenes encoding
non-ﬂuorescent proteins is only feasible, if rare cells
carrying desirable mutations can be enriched from the
bulk culture. As FACS sorting is ideal for selection, one
might attempt to tie the optimization of non-ﬂuorescent
proteins to ﬂuorescent signals. For example, a cell surface
receptor expressed on the surface of DT40 might be
optimized using a ﬂuorescent coupled ligand. Most likely,
the selection strategies will need to be customized
for diﬀerent types of proteins and the outcome of these
eﬀorts will determine the success of artiﬁcial evolution
in DT40.
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